Serving 500+ biopharmaceutical companies globally:
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
Serving 500+ biopharmaceutical companies globally:
Generated: July 24, 2017
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis Pharms Corp | VOTRIENT | pazopanib hydrochloride | TABLET;ORAL | 022465 | NDA | Novartis Pharmaceuticals Corporation | 0078-0670-66 | 120 TABLET, FILM COATED in 1 BOTTLE (0078-0670-66) | |||||||||||||||||||||
Novartis Pharms Corp | VOTRIENT | pazopanib hydrochloride | TABLET;ORAL | 022465 | NDA | GlaxoSmithKline LLC | 0173-0804-61 | 60 TABLET, FILM COATED in 1 BOTTLE (0173-0804-61) | |||||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
Serving 500+ biopharmaceutical companies globally:
Follow DrugPatentWatch:
Join the 22,104 others who get our Drug Patent Expiration Alerts:
